Follow-up of good clinical practice in the use and the maintenance of totally implantable ports: what benefits? Economic impact related to the use of positive-pressure secured Huber needles.
H. Levert and al.
Oral presentation at the 6^th French-speaking congress on long-term intravenous access devices, Paris, January 13-14, 2012.

Prolonged air leaks after pulmonary resection: a descriptive nation-wide study.
Rivera C, Bernard A, Falcoz P-E, Thomas P, Schmidt A, Bénard S, Vicaut E, Tiffet O, Filaire M and Dahan M.
Chirurgie Thoracique Cardio-Vasculaire - 2011;15(3):161-169. Link to the article

Characterization and prediction of prolonged air leak after pulmonary resection: a nation-wide study setting up the Index of Prolonged Air Leak.
Rivera C, Bernard A, Falcoz P-E, Thomas P, Schmidt A, Bénard S, Vicaut E and Dahan M.
Ann Thorac Surg. 2011 Sep;92(3):1062-8. Link to the article

Exelon^® in the management of Alzheimer patients: pharmaco-economic data.
Boussel J and Bénard S.
Oral presentation at the 10^th National Congress of Geriatrics Professionals, Paris, March 2011.

Evaluation of the cost of prenatal determination of the fœtal Rhesus D status from maternal plasma within at risk pregnant women in France.
Evaluation realized for the Haute Autorité de Santé (HAS) - January 2011. Voir l'avis.

Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France : XELOX versus FOLFOX-6.
Perrocheau G, Bennouna J, Ducreux M, Hebbar M, Ychou M, Lledo G, Conroy T, Dominguez S, Faroux R, Florentin V and Douillard JY.
Oncology 2010;79(3-4):174-80. Link to the article

Hospital undertaking of patients with a resection of lung tumor in France.
Cancalon C, Schmidt A and Bénard S.
Poster presented at the 13^th European congress of ISPOR, Prague, November 2010.

Evaluation of a hospital-home medical program (HHMP) for the management of chemotherapy-related toxicities in the outpatient setting.
Coriat R, Martin I, Forgeot d'Arc P, Mir O, Ropert S, Durand JP, Alexandre J,
Koba S, Goldwasser F.
Poster presented at the 35^th congress of the European Society for Medical Oncology (ESMO), Milan, October 2010.

Healthcare utilisation and costs of resected Squamous Cell Carcinoma of Head and Neck (SCCHN) in France.
Kim K, Faivre P, Cancalon C, Schmidt A, Amonkar M, Lykopoulos K, Bénard S, Högberg D, Kasteng F.
Poster presented at the European Society for Therapeutic Radiology and Oncology (ESTRO) congress, Barcelona, September 2010.

Opinion survey about actual use of a fentanyl patch, among nursing staff.
2010 Medical leaflet.

Prolonged Air Leak after pulmonary resection : analysis of national database EPITHOR (2004-2008).
Bernard A, Rivera C, Falcoz PE, Dahan M, Filaire M, Thomas PA, Vicaut E, Schmidt A and Bénard S. 2010 Red book of the French Society for Thoracic and Cardiovascular Surgery.
See the Red book

La base PMSI : outil épidémiologique et économique au niveau régional, exemple des cancers de la tête et du cou.
Cancalon C, Schmidt A and Bénard S.
Poster presented at the Association Des Epidémiologistes de Langue Française (ADELF) and EMOIS congress, Bordeaux, April 2010.

Annual cost estimation of Positron Emission Tomography (PET).
Health-economic study for the CNAMTS (Caisse Primaire d'Assurance Maladie des Travailleurs Salariés) in collaboration with the Syndicat National de Médecine Nucléaire (SNMN) and the Société Française de Médecine Nucléaire (SFMN) - April 2010.

Tooth decay prevention recommendations.
Public Health recommendations, Haute Autorité de Santé, Mars 2010.
Collaboration of st[è]ve consultants.
See the recommendations

Evaluation de l'impact d'un suivi téléphonique systématique des patients traités par chimio-antitumorale pour tumeurs solides.
Coriat R, Martin I, Forgeot d'Arc P, Ropert S, Durand JP, Brédard A, Levrat F, Schmidt A and Goldwasser F.
Poster presented at the Journées Francophones d'Hépato-gastroentérologie et d'Oncologie Digestive, (JFHOD), Paris, March 2010.

Pilot Study: Prospective analysis of blood sites' collection.
Public health study for the EFSAM (the Alps-Mediterranean French Blood Service) - February 2010.

Quality of life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer.
Conroy T, Hebbar M, Bennouna J, Ducreux M, Ychou M, Llédo G, Adenis A, Faroux R, Rebischung C, Kockler L and Douillard JY.
Br J Cancer 2010;102(1):59-67. Link to the article

Hospital burden related to upper aerodigestive tract cancers in France.
Cancalon C, Schmidt A and Bénard S.
Poster presented at the 12^th European congress of ISPOR, Paris, October 2009.

Bénéfices de la vaccination contre le rotavirus avec le vaccin pentavalent en France.
Huet F, Bénard S, Quilici S and Trichard M.
Oral presentation at the French Society of Paediatrics and Association of French speaking Pediatricians congress, Toulouse, June 2009.

Economic evaluation of a pentavalent universal rotavirus vaccination programme in France.
Bénard S and Quilici S.
Poster presented at the European Society for Paediatric Infectious Diseases (ESPID) congress, Brussels, June 2009.

Comment analyser l'impact médico-économique d'un nouveau programme de vaccination ? Exemple du vaccin pentavalent contre le rotavirus en France.
Quilici S, Bénard S, Trichard M and Huet F.
Oral presentation at the 4^th pharmaco-epidemiology conference, Paris, May 2009.

Health and Economic Impact associated with a quadrivalent HPV vaccine in Italy. Mennini FS, Giorgi Rossi P, Palazzo F and Largeron N.
Article written by st[è]ve consultants.
Gynecol Oncol 2009;112(2):370-6. Link to the article

Clinical, management and economic evaluation of an experimental treatment pattern in the prevention of periodontal diseases in 30-50 years old adults.
Study for MSA and UNM - December 2008.

Burden of rotavirus gastroenteritis and potential benefits of a pentavalent rotavirus vaccination in Belgium.
Dhont P, Trichard M, Largeron N, Rafia R and Bénard S.
J Med Econ 2008;11(3):431-448. Link to the article

Costs of herpes zoster and post-herpetic neuralgia in France.
Bénard S, Pinchinat S, Gallais JL, Mick G, Simon F and Beillat M.
Poster presented at the 11^th European congress of ISPOR, Athens, November 2008.

Cost of screening and treatment of cervical dyskaryosis in Germany.
Petry KU, Breugelmans JG, Bénard S, Lamure E, Littlewood K and Hillemanns P.
Eur J Gynaecol Oncol 2008;29(4):345-349. Link to the article

Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study
Hillemanns P, Breugelmans JG, Gieseking F, Bénard S, Lamure E, Littlewood K and Petry KU.
BMC Infectious Diseases 2008;8:76. Link to the article

Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland.
Szucs TD, Largeron N, Dedes KJ, Rafia R and Bénard S.
Curr Med Res Opin 2008;24(5):1473-1483. Link to the article

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: a cost-effectiveness analysis.
Kulasingam S, Bénard S, Barnabas R, Largeron N and Myers E.
Cost Eff Resour Alloc 2008;6:4. Link to the article

Evaluation of the oral health and needs in periodontal care among adults aged 30 to 50 years old.
Study for MSA and UNM - February 2008.

Swiss vaccination recommandations against human papillomavirus (HPV).
Federal office of public health - February 2008.

Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq® in France.
Huet F, Largeron N, Trichard M, Miadi-Farigier H and Jasso-Mosqueda G.
Article written by st[è]ve consultants.
Vaccine 2007;25(34):6348-6358. Link to the article

Evaluation of the needs in terms of vaccination, screening and treatment of HIV, hepatitis B and C and tuberculosis among a population in precariousness in the Ain area.
Study for the Public Health Center of Ain area - September 2007.

Coût de la prise en charge du cancer invasif du col de l'utérus en France (Invasive cervical cancer treatment costs in France).
Arveux P, Bénard S, Bouée S, Lafuma A, Martin L, Cravello L, Rémy V and Breugelmans G.
Bull Cancer 2007;94(2):219-224. Link to the article

Incidence, prise en charge et coût des condylomes acuminés anogénitaux chez les femmes consultant leur gynécologue en France.(Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France).
Monsonego J, Breugelmans G, Bouée S, Lafuma A, Bénard S and Rémy V.
Gynecol Obstet Fertil 2007;35:107-113. Link to the article

Coût du dépistage et de la prise en charge des lésions précancéreuses du col utérin en France (Cervical cancer screening and associated treatment costs in France).
Bergeron C, Breugelmans G, Boué S, Lorans C, Bénard S and Rémy V.
Gynecol Obstet Fertil. 2006. Vol.34 : 1036-1042. Link to the article

Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK.
Brown RE, Breugelmans G, Theodoratou D and Bénard S.
Curr Med Res Opin 2006;22(4):663-670. Link to the article

The development of a dynamic transmission model to assess the potential impact of a prophylactic quadrivalent HPV vaccine.
Breugelmans G, Garnett GF, Barnabas R and Bénard S.
Poster presented at the European Programme for Intervention Epidemiology Training (EPIET), Menorca, October 2005.

Cost-Effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis with multiple organ failure in France.
Riou-França L, Launois R, Guidet B, Aegerter P, Bénard S, Pinton P and Meshaka P.
Poster presented at the International Health-Economic Association (iHEA), San Francisco, July 2003.